Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 240-247

  Puranik, Rajesh ^a,b   Bao, Shisan ^a,b   Nobecourt, Estelle ^a   Nicholls, Stephen J ^a   Dusting, Gregory J ^c   Barter, Philip J ^a,b   Celermajer, David S ^a,b   Rye, Kerry Anne ^a,b,c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acute inflammation; Apolipoprotein A I; High density lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; INTERCELLULAR ADHESION MOLECULE 1;

ACUTE CORONARY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAROTID ARTERY DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

ANIMALS; APOLIPOPROTEIN A-I; CAROTID ARTERY DISEASES; DISEASE MODELS, ANIMAL; INFLAMMATION; INFUSIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, HDL; MALE; PEROXIDASE; RABBITS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 38049013311     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.05.008     Document Type: Article

References (22)

1. Wilson P.W., Abbott R.D., and Castelli W.P. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8 (1988) 737-741
2. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15 (1995) 1987-1994
3. Navab M., Imes S.S., Hama S.Y., et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin Invest 88 (1991) 2039-2046
4. Diederich W., Orso E., Drobnik W., and Schmitz G. Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. Atherosclerosis 159 (2001) 313-324
5. Dimayuga P., Zhu J., Oguchi S., et al. Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice. Biochem Biophys Res Commun 264 (1999) 465-468
6. Rong J.X., Li J., Reis E.D., et al. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation 104 (2001) 2447-2452
7. Cockerill G.W., McDonald M.C., Mota-Filipe H., et al. High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock. FASEB J. 15 (2001) 1941-1952
8. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
9. Nicholls S.J., Dusting G.J., Cutri B., et al. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 111 (2005) 1543-1550
10. Osborne Jr. J.C. Delipidation of plasma lipoproteins. Methods Enzymol 128 (1986) 213-222
11. Weisweiler P. Isolation and quantitation of apolipoproteins A-I and A-II from human high-density lipoproteins by fast-protein liquid chromatography. Clin Chim Acta 169 (1987) 249-254
12. Dusting G.J., Curcio A., Harris P.J., et al. Supersensitivity to vasoconstrictor action of serotonin precedes the development of atheroma-like lesions in the rabbit. J. Cardiovasc Pharmacol 16 (1990) 667-674
13. Bao S., Beagley K.W., France M.P., Shen J., and Husband A.J. Interferon-gamma plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 99 (2000) 464-472
14. Allen J.K., Hensley W.J., Nicholls A.V., and Whitfield J.B. An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem 25 (1979) 325-327
15. Eugui J., Logrono M.J., Ruiz R., et al. Immunoturbidimetry of serum apolipoproteins A-I and B on the Cobas Bio centrifugal analyzer: method validation and reference values. Clin Biochem 27 (1994) 310-315
16. Paterno R., Ruocco A., Postiglione A., et al. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 17 (2004) 204-211
17. Nicholls S.J., Cutri B., Worthley S.G., et al. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 25 (2005) 2416-2421
18. Baker P.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res 40 (1999) 345-353
19. Baker P.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res 41 (2000) 1261-1267
20. Liao X.L., Lou B., Ma J., and Wu M.P. Neutrophils activation can be diminished by apolipoprotein A-I. Life Sci 77 (2005) 325-335
21. Blackburn Jr. W.D., Dohlman J.G., Venkatachalapathi Y.V., et al. Apolipoprotein A-I decreases neutrophil degranulation and superoxide production. J Lipid Res 32 (1991) 1911-1918
22. Kopprasch S., Pietzsch J., and Graessler J. The protective effects of HDL and its constituents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL. Mol Cell Biochem 258 (2004) 121-127